Damage of motor neurons in Amyotrophic Lateral Sclerosis (ALS) is long and arduous, both for patients and the ALS community. ALS is an unforgiving disease that strips its’ victims of independence and their breath. That is why the focus of advanced research initiatives in ALS and similar diseases must be on innovation. Symptomatic treatments have their place, and although the advocacy community has brought various drug studies to focus, patients of ALS are also interested in conducive therapies which focus on decaying neural pathways in not only ALS but other neuro ailments. ALS is patient to its victims in its slow progression, but for the rest of the world, its victims are lost. Most of the research that the community is passionate about is related to symptomatic treatments which would lead to a better quality of life for patients.
The Disconcerting Complexity
The disconcerting complexity of diseases like ALS is near incomprehensible. All neurological diseases share the disconcerting analogy of losing nerve structures and the ability to impulse nerves and muscles peripherally. ALS robs its victims of the ability to mechanically function. The mechanical function loss manifests in disconcerting passive structural changes. TDP-43 misarrangement disrupting the functions of RNA in the nucleus, consequently destroying the nucleus. A large proportion of the loss of the SNS (somatic nervous system) is mapped to the loss of neurons and tissues by a process of excitotoxicity. It is a process in which a neuron is bathed in a toxic concentration of calcium, which then causes a cascade of destruction by calcium fulfillment. Increased level of excitotoxicity leads to a cascade of neuronal tissue destruction and loss. Increased dysfunction of the mitochondria of neurons contributes to the loss of the integrity of neuronal tissues, gradually forming a cascade in the tissues of the neuronal system characterized by excitotoxicity. Numerous studies have documented the loss of elastin in the connective tissue of the brain due to excitotoxicity. Identifying damage-elevating factors is the first step to rapid improvement and progression of treatment. Standardized Protocol for Treatment of Multiple Neurosclerosis with Accompanying Motor Neuron Injury with Severe and Accompanying Progressing Neuropathy (MPN) focuses on alleviating external symptoms. In order to try and decrease the amount of glutamate circulating in the system, or the stress of oxidation, some physicians may attempt to prescribe a specific substance. Supplements of nerves for nutrition, nursing, and positive physical aid proceed to take on singular and inclusive personal, extensive, and post-surgical measures. In traditional medicine, the focus is to fill the missing gaps left by dead neurons. This is the crucial moment where the worldwide medical community is to react, Thus Natural Cellular Regeneration comes to changes the way of ALS treatment.
Figure 1: The Disconcerting Complexity of ALS
Stem Cells therapy to changes ALS treatment
Stem cell therapy brings a different dimension to the real treatment ALS. The non-embryonic isolated mesenchymal stem cells, which the clinical researchers employ, command the acceleration of the Natural Cellular Regeneration of the broken tissues in the spinal column. These cells have the ability to modulate the immune system. When introduced to a damaged center of the nervous system, the cells have the ability to secrete some important neurotrophic factors – brain derived neurotrophic factor (BDNF) and glial cell line derived neurotrophic factor (GDNF). The factors offer sanctuary to the remaining motor neurons while the effects of excitotoxicity. The cells to be introduced promote the restoration of the complex neural scaffolding in the decreased neurogenesis. The cells are also able to supplement the motor neurons with good mitochondria. This therapy is said to regress the illness’s motor functions.
Figure 2: Stem Cells therapy to changes ALS treatment
Therapeutic Trends in Thailand
There is good news for the devastating neurodegenerative illness therapy in the medical world of Southeast Asia. Thailand is the leader in Natural Cellular Regeneration. He has excellent healthcare, including legal structures, and safely brings new cell therapy to practice. Unlike the majority of Western countries, the introduction of cerebral neuro therapy in Thailand calls for an extended period of time. But the integration of the medical and healthcare system, skilled practitioners, and advanced medical technology, on top of innovative policy, allows Thailand to be at the forefront of treating severe neuro diseases. With all that said, the country is now able to provide that sophisticated ALS therapy.
Dealing with the phenomenon of ALS enhanced approaches in the field, and not conventional methods of symptom control. The use of stem cells and further development in the field of Natural Cellular Regeneration, has brought the field closer to not only achieving neural restoration, but the full Robotic healing aspect. Leading medical centers like those in Thailand continue to develop innovative techniques in this area and help bring the field to the final stages of the restoration of advanced neuro degeneration with the loss of neural function. It is this aspect of advanced medical research that motivates the evolution of these biological restoration hypotheses to clinical practice.